Biogen
BIIB
#991
Rank
ยฃ14.95 B
Marketcap
ยฃ102.15
Share price
-3.52%
Change (1 day)
-40.35%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) Fails to deliver data

Key failure to deliver metrics for Biogen:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Biogen (BIIB) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Biogen (BIIB) - since 2013

Volume in USD (price x number of shares), data since 2013

Biogen (BIIB) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ21.31 M-70.36%
2024ยฃ71.88 M27.44%
2023ยฃ56.4 M-14.65%
2022ยฃ66.08 M7.92%
2021ยฃ61.24 M-56.04%
2020ยฃ0.13 B67.82%
2019ยฃ83.01 M-43.79%
2018ยฃ0.14 B69.32%
2017ยฃ87.22 M-29.4%
2016ยฃ0.12 B-16.47%
2015ยฃ0.14 B-18.15%
2014ยฃ0.18 B579.65%
2013ยฃ26.59 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
ยฃ97.9 Mยฃ0.29 B๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.58 Mยฃ97.36 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ34.68 Mยฃ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.79 Mยฃ0.34 B๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ16.63 Mยฃ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
N/Aยฃ0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.86 Mยฃ53.59 M๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ0.84 Mยฃ14.37 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ16.56 Mยฃ70.3 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.22 Mยฃ2.22 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands